期刊文献+

晚期非小细胞肺癌单克隆抗体治疗的研究进展 被引量:1

暂未订购
导出
摘要 肺癌是发病率最高的恶性肿瘤之一,临床报道显示[1-2],我国城市恶性肿瘤中肺癌发生率居首位.肺癌按细胞形态可以分为小细胞肺癌(Small cell lung cancer,SCLC)和非小细胞肺癌(Non-small cell lung cancer,NSCLC).非小细胞肺癌作为最常见的肺癌类型之一,占肺癌患者数75%~80%[3-4].随着人们对肿瘤发生过程中分子机制研究的深入,逐渐发展起了以肿瘤发生过程中一些关键分子为靶点的靶向治疗(Molecular targeted therapy).
作者 江山 杨小琼
出处 《吉林医学》 CAS 2013年第35期7482-7483,共2页 Jilin Medical Journal
  • 相关文献

参考文献15

二级参考文献87

  • 1周彩存,钟文昭.吉西他滨联合铂类与其他含铂方案治疗晚期非小细胞肺癌的疗效比较:关于生存结果的荟萃分析[J].循证医学,2005,5(3):143-146. 被引量:70
  • 2潘启超.长春碱类的新进展──失碳长春碱[J].癌症,1996,15(3):228-231. 被引量:276
  • 3管忠震,梅尉德.肿瘤内科诊治手册[M].合肥:安徽科学技术出版社,2006:64,66.
  • 4吴金瓦,赵昌罗.实用肿瘤治疗手册[M].杭州:浙江科学技术出版社,2001:803-804.
  • 5[1]Miller RA. Treatmcnt of B-cell lymphoma with monoclonal anti-idiotype antibody[J].New Engl J Med,1982,306(9):517-522.
  • 6[2]Cobleigh M. Efficacy and safety of herceptin (humanized anti-HER-2 antibody) as a single agent in 222 women with HER-2 overexpression who relapsed following chemotherapy for metastatic breast cancer[J].Proc Am Soc Clin Oncol,1998,17:376.
  • 7[3]Slamon DJ,Leyland-Jones B,Shak S,et al. Addition of herceptin (humanized anti-HER-2 antibody) to first line chemotherapy for HER-2 overexpressing metastatic breast cancer markedly increases anti-cancer activity[J].Proc Am Soc Clin Oncol,1998,17:377.
  • 8[4]Seidman AD,Fornier M,Esteva F,et al. Final report: weekly herceptin and taxol for metastatic breast cancer: analysis of efficacy by HER-2 immunophenotype [immunohistochemistry (IHC)] and gene amplification [fluorescent in-situ hybridization (FISH)][J].Proc Am Soc Clin Oncol,2000,19:319.
  • 9[5]Nicholson BP,Thor AD,Goldstein LJ,et al. Weekly docetaxel and rhumabher combination therapy as first or second line treatment for metastatic breast cancer[J].Proc Am Soc Clin Oncol,2000,19:549.
  • 10[6]Burstein HJ,Kuter I,Richardson PG,et al. Herceptin and vinorelbine for HER-2 positive metastatic breast cancer: a phase Ⅱ study[J].Proc Am Soc Clin Oncol,2000,19:392.

共引文献40

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部